Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
7.50
+0.21 (2.88%)
Mar 9, 2026, 2:58 PM EDT - Market open
Adicet Bio Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
152
Market Cap
75.80M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Champions Oncology | 58.42M |
| Pelthos Therapeutics | 7.41M |
| Coeptis Therapeutics Holdings | 501.00K |
| MediciNova | 409.66K |
| aTyr Pharma | 190.00K |
| Impact BioMedical | 25.00K |
| Fractyl Health | 3.00K |
ACET News
- 5 weeks ago - Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - Business Wire
- 2 months ago - Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones - Business Wire
- 2 months ago - Adicet Bio Announces Reverse Stock Split - Business Wire
- 3 months ago - Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 months ago - Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire
- 4 months ago - Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 months ago - Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference - Business Wire
- 5 months ago - Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA) - Business Wire